Literature DB >> 3014702

Acute hemorrhagic cystitis caused by adenovirus type 11 after renal transplantation.

K Shindo, T Kitayama, T Ura, F Matsuya, Y Kusaba, H Kanetake, Y Saito.   

Abstract

A case of acute hemorrhagic cystitis caused by adenovirus type 11, which occurred in an allograft recipient 6 months after a living-related renal transplantation, is described. The patient lacked a neutralizing antibody to adenovirus type 11 before transplantation. Adenovirus type 11 was isolated from his urine and he developed a neutralizing and complement-fixing antibody to this virus. Although adenovirus type 11 isolates had been obtained from 2 of 18 renal allograft recipients, only 1 patient suffered acute hemorrhagic cystitis. Adenovirus type 11 may play a role in acute hemorrhagic cystitis in renal allograft recipients during immunosuppressive therapy.

Entities:  

Mesh:

Year:  1986        PMID: 3014702     DOI: 10.1159/000281186

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

1.  Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines.

Authors:  A Segerman; Y F Mei; G Wadell
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  Adenovirus pyelonephritis in a pediatric renal transplant patient.

Authors:  Sarah S Kim; John Hicks; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2003-03-18       Impact factor: 3.714

3.  Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers.

Authors:  Y F Mei; G Wadell
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 4.  Adenoviruses in the immunocompromised host.

Authors:  J C Hierholzer
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

5.  Infectious human adenoviruses are shed in urine even after disappearance of urethral symptoms.

Authors:  Nozomu Hanaoka; Shin Ito; Masami Konagaya; Naomi Nojiri; Mitsuru Yasuda; Tsuguto Fujimoto; Takashi Deguchi
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.